Previous close | 12.48 |
Open | 12.48 |
Bid | 17.60 |
Ask | 22.50 |
Strike | 65.00 |
Expiry date | 2024-07-19 |
Day's range | 12.48 - 12.48 |
Contract range | N/A |
Volume | |
Open interest | 21 |
Exact Sciences (EXAS) has numerous competitors, given the large market for colorectal cancer screening.
Exact Sciences' (EXAS) latest study research result shows commitment to innovation and strategies that expand access to effective cancer screening and diagnostic tools for patients.
MADISON, Wis., May 28, 2024--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.